Significance of targeting polyamine metabolism as an antineoplastic strategy: Unique targets for polyamine analogues

Proceedings of the Western Pharmacology Society

Volumn 48, Issue , 2005, Pages 24-30

  Casero Jr , Robert A ^a   Frydman, Benjamin ^b   Stewart, Tracy Murray ^a   Woster, Patrick M ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SLIL Biomedical Corp   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMIDINO 1 INDANONE 2' AMIDINOHYDRAZONE; ACYLTRANSFERASE; CG 11093; CG 11144; CG 11150; CG 11158; EFLORNITHINE; FLUOROURACIL; N1 (2 METHYL 1 BUTYL) N11 ETHYL 4,8 DIAZAUNDECANE; N1 ETHYL N11 (CYCLOHEPTYL)METHYL 4,8 DIAZAUNDECANE; N1 ETHYL N11 (CYCLOPROPYL)METHYL 4,8 DIAZAUNDECANE; N1,N11 DIETHYLNORSPERMINE; ORNITHINE DECARBOXYLASE; POLYAMINE; POLYAMINE DERIVATIVE; PUTRESCINE; S ADENOSYLMETHIONINE; SPERMIDINE; SPERMINE; SPERMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER; CANCER GROWTH; CANCER RESEARCH; CARCINOGENESIS; CATABOLISM; CATALYSIS; CELL GROWTH; CELL TYPE; CLINICAL PATHWAY; CLINICAL TRIAL; CONFERENCE PAPER; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; DRUG TOLERABILITY; ENZYME REGULATION; EUKARYOTE; HUMAN; LUNG CANCER; MELANOMA; NONHUMAN; PANCREAS CANCER; POLYAMINE METABOLISM; POLYAMINE SYNTHESIS; PRECANCER; REGULATORY MECHANISM;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOGENIC POLYAMINES; HUMANS; POLYAMINES;

EID: 30144433680     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (62)

1. Gerner, E.W. and Meyskens, F.L., Jr. (2004) Polyamines and cancer: old molecules, new understanding. 4, 781-792.
2. Marion, L.J. and Pegg, A.E. (1995) Ann. Rev. Pharmacol. Toxicol. 35, 55-91.
3. Celano, P., Berchtold, C.M., Giardiello, F.M. and Casero, R.A., Jr. (1989) Biochem. Biophys. Res. Commun. 165, 384-390.
4. Celano, P., Baylin, S.B. and Casero, R.A., Jr. (1989) J. Biol. Chem. 264, 8922-8927.
5. Wang, J.Y., McCormack, S.A., Viar, M.J., Wang, H., Tzen, C.Y., Scott, R.E. and Johnson, L.R. (1993) Am. J. Physiol. 265, G331-338.
6. Wang, J.Y. and Johnson, L.R. (1994) Am. J. Physiol. 266, G878-886.
7. Williams, K. (1997) Biochem. J. 325, 289-297.
8. Igarashi, K. and Kashiwagi, K. (2000) Biochem Biophys. Res. Commun. 271, 559-564.
9. Ha, H.C., Sirisoma, N.S., Kuppusamy, P., Zweier, J.L., Woster, P.M. and Casero, R.A., Jr. (1998) Proc. Natl. Acad. Sci. USA. 95, 11140-11145.
10. Wallace, H.M., Fraser, A.V. and Hughes, A. (2003) Biochem. J. 376, 1-14.
11. Wallace, H.M. and Fraser, A.V. (2003) Biochem. Soc. Trans. 31, 393-396.
12. Pegg, A.E. (1988) Cancer Res. 48, 759-774.
13. Pegg, A.E., Shantz, L.M. and Coleman, C.S. (1994) Biochem. Soc. Trans. 22, 846-852.
14. Russell, D. and Snyder, S.H. (1968) Proc. Natl. Acad. Sci. USA. 60, 1420-427.
15. Pegg, A.E. and Williams-Ashman, H.G. (1968) Biochem. J. 109, 32P-33P.
16. Hayashi, S., Murakami, Y. and Matsufuji, S. (1996) Trends Biochem. Sci. 21, 27-30.
17. Pegg, A.E., Xiong, H., Feith, D.J. and Shantz, L.M. (1998) Biochem. Soc. Trans. 26, 580-586.
18. Delia Ragione, F., Russo, G., Oliva, A., Mastropietro, S., Mancini, A., Borrelli, A., Casero, R. A., Iolascon, A. and Zappia, V. (1995) Oncogene 10, 827-833.
19. Seiler, N. (1995) Prog. Brain Res. 106, 333-344.
20. Casero, R.A., Jr. and Pegg, A.E. (1993) FASEB J. 7, 653-661.
21. Casero, R.A., Jr., Celano, P., Ervin, S.J., Wiest, L. and Pegg, A.E. (1990) Biochem. J. 270, 615-620.
22. Casero, R.A., Jr., Celano, P., Ervin, S.J., Applegren, N.B., Wiest, L. and Pegg, A.E. (1991) J. Biol. Chem. 266, 810-814.
23. Porter, C.W., Ganis, B., Libby, P.R. and Bergeron, R.J. (1991) Cancer Res. 51, 3715-3720.
24. Fogel-Petrovic, M., Vujcic, S., Brown, P.J., Haddox, M.K. and Porter, C.W. (1996) Biochemistry 35, 14436-14444.
25. Xiao, L. and Casero, R.A., Jr. (1996) Biochem. J. 313 ( Pt 2), 691-696.
26. Fogel-Petrovic, M., Vujcic, S., Miller, J. and Porter, C.W. (1996) FEBS Lett. 391, 89-94.
27. Gerner, E.W., Kurtts, T.A., Fuller, D.J. and Casero, R.A., Jr. (1993) Biochem. J. 294, 491-495.
28. Parry, L., Balana Fouce, R. and Pegg, A.E. (1995) Biochem. J. 305, 451-458.
29. Coleman, C.S. and Pegg, A.E. (2001) Biochem. J. 358, 137-145.
30. Coleman, C.S. and Pegg, A.E. (1997) res the carboxyl-terminal glutamic acid residues. J. Biol. Chem. 272, 12164-12169.
31. Wang, Y., Devereux, W., Woster, P.M., Stewart, T.M., Hacker, A. and Casero, R.A., Jr. (2001) Cancer Res. 61, 5370-5373.
32. Wang, Y., Murray-Stewart, T., Devereux, W., Hacker, A., Frydman, B., Woster, P.M. and Casero, R.A. (2003) Biochem. Biophys. Res. Commun. 304, 605-611.
33. Vujcic, S., Diegelman, P., Bacchi, C.J., Kramer, D.L. and Porter, C.W. (2002) Biochem. J. 367, 665-675.
34. Cervelli, M., Polticelli, F., Federico, R. and Mariottini, P. (2003) J. Biol. Chem. 278, 5271-5276.
35. Wang, Y., Hacker, A., Murray-Stewart, T., Fleischer, J.G., Woster, P.M. and Casero, R.A., Jr. (2005) Biochem. J. 386, 543-547.
36. McCann, P.P. and Pegg, A.E. (1992) Pharmacol. Ther. 54, 195-215.
37. Abeloff, M.D., Rosen, S.T., Luk, G.D., Baylin, S.B., Zeltzman, M. and Sjoerdsma, A. (1986) Cancer Treat. Rep. 70, 843-845.
38. Van Nieuwenhove, S., Schechter, P.J., Declercq, J., Bone, G., Burke, J. and Sjoerdsma, A. (1985) Trans. R. Soc. Trop. Med. Hyg. 79, 692-698.
39. Regenass, U., Mett, H., Stanek, J., Mueller, M., Kramer, D. and Porter, C.W. (1994) Cancer Res. 54, 3210-3217.
40. Svensson, F., Mett, H. and Persson, L. (1997) Biochem. J. 322 (Pt 1), 297-302.
41. Paridaens, R., Uges, D.R., Barbet, N., Choi, L., Seeghers, M., van der Graaf, W.T., Groen, H.J., Dumez, H., Buuren, I.V., Muskiet, F., Capdeville, R., Oosterom, A.T. and de Vries, E.G. (2000) Br. J. Cancer 83, 594-601.
42. Pless, M., Belhadj, K., Menssen, H.D., Kern, W., Coiffier, B., Wolf, J., Herrmann, R., Thiel, E., Bootle, D., Sklenar, I., Muller, C., Choi, L., Porter, C. and Capdeville, R. (2004) Clin. Cancer Res. 10, 1299-1305.
43. Bergeron, R.J., Neims, A.M., McManis, J.S., Hawthorne, T.R., Vinson, J.R., Bortell, R. and Ingeno, M.J. (1988) J. Med. Chem. 31, 1183-1190.
44. Casero, R.A. and Woster, P.M. (2001) J. Med. Chem. 44, 1-26.
45. Frydman, B., Blokhin, A.V., Brummel, S., Wilding, G., Maxuitenko, Y., Sarkar, A., Bhattacharya, S., Church, D., Reddy, V.K., Kink, J.A., Marton, L.J., Valasinas, A. and Basu, H.S. (2003) J. Med. Chem. 46, 4586-4600.
46. Casero, R.A., Jr., Celano, P., Ervin, S.J., Porter, C.W., Bergeron, R.J. and Libby, P.R. (1989) Cancer Res. 49, 3829-3833.
47. Casero, R.A., Jr., Ervin, S.J., Celano, P., Baylin, S.B. and Bergeron, R.J. (1989) Cancer Res. 49, 639-643.
48. Ha, H.C., Woster, P.M., Yager, J.D. and Casero, R.A., Jr. (1997) Proc. Natl. Acad. Sci. USA. 94, 11557-11562.
49. Chen, Y., Kramer, D.L., Diegelman, P., Vujcic, S. and Porter, C.W. (2001) Cancer Res. 61, 6437-6444.
50. Vujcic, S., Halmekyto, M., Diegelman, P., Gan, G., Kramer, D.L., Janne, J. and Porter, C.W. (2000) J. Biol. Chem. 275, 38319-38328.
51. Murray-Stewart, T., Applegren, N.B., Devereux, W., Hacker, A., Smith, R., Wang, Y. and Casero, R.A., Jr. (2003) Biochem. J. 373, 629-634.
52. Hahm, H.A., Ettinger, D.S., Bowling, K., Hoker, B., Chen, T.L., Zabelina, Y. and Casero, R.A., Jr. (2002) Clin. Cancer Res. 8, 684-690.
53. Wolff, A.C., Armstrong, O.K., Petting, J.H., Carducci, M.K., Riley, C.D., Bender, J.F., Casero, R.A., Jr. and Davidson, N.E. (2003) Clin. Cancer Res. 9, 5922-5928.
54. Hector, S., Porter, C.W., Kramer, D.L., Clark, K., Prey, J., Kisiel, N., Diegelman, P., Chen, Y. and Pendyala, L. (2004) Mol. Cancer Ther. 3, 813-822.
55. Choi, W., Gerner, E.W., Ramdas, L., Dupart, J., Carew, J., Proctor, L., Huang, P., Zhang, W. and Hamilton, S.R. (2005) J. Biol. Chem. 280, 3295-3304.
56. Valasinas, A., Sarkar, A., Reddy, V.K., Marton, L.J., Basu, H.S. and Frydman, B. (2001) J. Med. Chem. 44, 390-403.
57. Huang, Y., Hager, E.R., Phillips, D.L., Hacker, A., Frydman, B., Valasinas, A.L., Reddy, V.K., Marton, L.J., Casera, R.A. and Davidson, N.E. (2002) Pro. Amer. Assoc. Cancer Res. 43, 90.
58. Valasinas, A., Reddy, V.K., Blokhin, A.V., Basu, H.S., Bhattacharya, S., Sarkar, A., Marton, L.J. and Frydman, B. (2003) Bioorg. Med. Chem. 11, 4121-131.
59. Huang, Y., Keen, J.C., Hager, E., Smith, R., Hacker, A., Frydman, B., Valasinas, A.L., Reddy, V.K., Marton, L.J., Casera, R.A., Jr. and Davidson, N.E. (2004) Mol. Cancer Res. 2, 81-88.
60. Mitchell, J.L., Leyser, A., Holtorff, M.S., Bates, J.S., Frydman, B., Reddy, V.K. and Marton, L.J. (2002) Biochem. J. 366, 663-671.
61. Huang, Y., Hager, E.R., Phillips, D.L., Dunn, V.R., Hacker, A., Frydman, B., Kink, J.A., Valasinas, A.L., Reddy, V.K., Marton, L.J., Casera, R.A., Jr. and Davidson, N.E. (2003) Clin. Cancer Res. 9, 2769-2777.
62. Wang, Y., Hacker, A., Murray-Stewart, T., Frydman, B., Valasinas, A., Fraser, A.V., Woster, P.M. and Casera, R.A., Jr. (2005) Cancer Chemother. Pharmacol.